-
EP4360651
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4360651
| EP4360651 - GLP-1 COMPOSITIONS AND USES THEREOF [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 12.03.2026 Database last updated on 08.04.2026 | |
| Former | Request for examination was made Status updated on 24.01.2025 | ||
| Former | The application has been published Status updated on 29.03.2024 | Most recent event Tooltip | 13.03.2026 | First examination report | Applicant(s) | For all designated states Novo Nordisk A/S Novo Allé 2880 Bagsværd / DK | [2024/18] | Inventor(s) | 01 /
HORN MØLLER, Eva 2880 Bagsværd / DK | 02 /
DUELUND SØRENSEN, Michael 2880 Bagsværd / DK | 03 /
LUNDQVIST, Joakim 2880 Bagsværd / DK | [2024/18] | Application number, filing date | 24155461.7 | 24.08.2018 | [2024/18] | Priority number, date | EP20170187676 | 24.08.2017 Original published format: EP 17187676 | [2024/18] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP4360651 | Date: | 01.05.2024 | Language: | EN | [2024/18] | Type: | A3 Search report | No.: | EP4360651 | Date: | 17.07.2024 | Language: | EN | [2024/29] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 18.06.2024 | Classification | IPC: | A61K9/00, A61K38/00, A61K47/10, A61K9/08, A61K47/02, A61P3/04, A61P3/10, A61K38/26 | [2024/29] | CPC: |
A61K9/0019 (EP,CN,IL,KR,US);
A61K38/26 (EP,CN,IL,KR,US);
A61K9/08 (EP,CN,IL,KR,US);
A61K47/02 (EP,CN,IL,US);
A61K47/10 (EP,CN,IL,KR,US);
A61P3/04 (EP,CN,IL,KR);
A61P3/10 (EP,CN,IL,KR)
(-)
|
| Former IPC [2024/18] | A61K47/10 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/18] | Validation states | MA | 17.01.2025 | TN | 17.01.2025 | Title | German: | GLP-1-ZUSAMMENSETZUNGEN UND VERWENDUNGEN DAVON | [2024/18] | English: | GLP-1 COMPOSITIONS AND USES THEREOF | [2024/18] | French: | COMPOSITIONS GLP-1 ET LEURS UTILISATIONS | [2024/18] | Examination procedure | 10.01.2025 | Amendment by applicant (claims and/or description) | 17.01.2025 | Examination requested [2025/09] | 17.01.2025 | Date on which the examining division has become responsible | 11.03.2026 | Despatch of a communication from the examining division (Time limit: M04) | Parent application(s) Tooltip | EP18756449.7 / EP3474820 | Fees paid | Renewal fee | 03.06.2024 | Renewal fee patent year 03 | 03.06.2024 | Renewal fee patent year 04 | 03.06.2024 | Renewal fee patent year 05 | 03.06.2024 | Renewal fee patent year 06 | 02.09.2024 | Renewal fee patent year 07 | 01.09.2025 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XA] WO2014060472 (NOVO NORDISK AS et al.) | [DA] WO2006097537 (NOVO NORDISK AS et al.) | [A] BASF: "BASF Chemical Emergency Medical Guidelines", 1 January 2016 (2016-01-01), XP055427004, Retrieved from the Internet | by applicant | WO2006097537 | WHO DRUG INFORMATION, vol. 24, no. 1, 2010 | NAIKI ET AL., ANAL. BIOCHEM., vol. 177, 1989, pages 244 - 249 | LEVINE, METHODS. ENZYMOL., vol. 309, 1999, pages 274 - 284 |